you would imagine the strength of the data would have to make the possibility of conditional marketing approval in the sub groups a big chance
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-15
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $454.5M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $92.49K | 297.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 111435 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 78101 | 12 |
View Market Depth
| Last trade - 10.55am 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |